430 related articles for article (PubMed ID: 16391392)
1. Intravenous immunoglobulin: adverse effects and safe administration.
Orbach H; Katz U; Sherer Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):173-84. PubMed ID: 16391392
[TBL] [Abstract][Full Text] [Related]
2. Safety of intravenous immunoglobulin (IVIG) therapy.
Katz U; Achiron A; Sherer Y; Shoenfeld Y
Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
[TBL] [Abstract][Full Text] [Related]
3. Adverse effects of IgG therapy.
Berger M
J Allergy Clin Immunol Pract; 2013; 1(6):558-66. PubMed ID: 24565701
[TBL] [Abstract][Full Text] [Related]
4. Acute renal failure after large doses of intravenous immune globulin.
Haskin JA; Warner DJ; Blank DU
Ann Pharmacother; 1999; 33(7-8):800-3. PubMed ID: 10466908
[TBL] [Abstract][Full Text] [Related]
5. Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases.
Tufan F; Kamali S; Erer B; Gul A; Inanc M; Ocal L; Konice M; Aral O
Clin Rheumatol; 2007 Nov; 26(11):1913-5. PubMed ID: 17636363
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin-associated acute renal failure: case series and literature review.
Itkin YM; Trujillo TC
Pharmacotherapy; 2005 Jun; 25(6):886-92. PubMed ID: 15927908
[TBL] [Abstract][Full Text] [Related]
7. Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies.
Brannagan TH
Neurology; 2002 Dec; 59(12 Suppl 6):S33-40. PubMed ID: 12499469
[TBL] [Abstract][Full Text] [Related]
8. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
[TBL] [Abstract][Full Text] [Related]
9. [Adverse effects of administration of intravenous human immunoglobulins].
Bednarík J; Kadanka Z
Cas Lek Cesk; 1999 Nov; 138(21):647-9. PubMed ID: 10746020
[TBL] [Abstract][Full Text] [Related]
10. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
[TBL] [Abstract][Full Text] [Related]
11. Immediate adverse reactions to intravenous immunoglobulin in children: a single center experience.
Kaba S; Keskindemirci G; Aydogmus C; Siraneci R; Erol Cipe F
Eur Ann Allergy Clin Immunol; 2017 Jan; 49(1):11-14. PubMed ID: 28120600
[TBL] [Abstract][Full Text] [Related]
12. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
Chapman SA; Gilkerson KL; Davin TD; Pritzker MR
Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143
[TBL] [Abstract][Full Text] [Related]
13. Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusions.
Bichuetti-Silva DC; Furlan FP; Nobre FA; Pereira CT; Gonçalves TR; Gouveia-Pereira M; Rota R; Tavares L; Mazzucchelli JT; Costa-Carvalho BT
Int Immunopharmacol; 2014 Dec; 23(2):442-6. PubMed ID: 25257732
[TBL] [Abstract][Full Text] [Related]
14. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study.
Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):314-9. PubMed ID: 21953992
[TBL] [Abstract][Full Text] [Related]
15. Special considerations with the use of intravenous immunoglobulin in older persons.
Cheng MJ; Christmas C
Drugs Aging; 2011 Sep; 28(9):729-36. PubMed ID: 21913738
[TBL] [Abstract][Full Text] [Related]
16. Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J; Casey CG; Bell DM;
MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulins for rheumatic disorders and thromboembolic events-a case series and review of the literature.
Lidar M; Masarwa S; Rotman P; Carmi O; Rabinowicz N; Levy Y
Immunol Res; 2018 Dec; 66(6):668-674. PubMed ID: 30565202
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolic complications of intravenous immunoglobulin treatment.
Vucic S; Chong PS; Dawson KT; Cudkowicz M; Cros D
Eur Neurol; 2004; 52(3):141-4. PubMed ID: 15479982
[TBL] [Abstract][Full Text] [Related]
19. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
[TBL] [Abstract][Full Text] [Related]
20. Adverse effects of intravenous immunoglobulin.
Misbah SA; Chapel HM
Drug Saf; 1993 Oct; 9(4):254-62. PubMed ID: 8260119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
